Analyzing the Global Pharmaceutical Industry 2015
The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent.
By contribution of size, the pharmaceutical industry is majorly dominant at the US, Asia Pacific. Led by these markets, the total world consumption in sales of pharmaceutical products has displayed strong growth and is expected to grow further with expanding populations in emerging markets.
However, in recent times, austerity measures across the world along with many countries imposing cutbacks on healthcare spending (particularly in Europe), has hit the pharmaceutical industry. Furthermore, the loss of patent for many blockbuster drugs during the years 2010-2015 is also going to have a big impact on the global pharmaceutical industry. However, generic manufacturers are likely to benefit from this as they are poised to capture a substantial portion of revenues with their generic versions of these drugs.
Aruvian’s Research’s report – Analyzing the Global Pharmaceutical Industry – presents a complete analysis of the global pharmaceutical industry by setting up an industry demarcation and providing a study on marketing dynamic of the industry like segments active in the industry, competitive activity and the overall market outlook. The global pharmaceutical industry is analyzed in this in-depth report through industry statistics (data ranging from 2009 to 2018), industry value, industry segmentation, an analysis of market share, competitive landscape and an industry forecast till 2018.
